Pictet Asset Management (Switzerland)’s Agios Pharmaceuticals AGIO Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$25M	Buy	882,402 +186,326	+27%	+$4.64M	0.03%	416
2023 Q1	$16M	Buy	696,076 +430,358	+162%	+$11.4M	0.02%	517
2022 Q4	$7.46M	Buy	265,718 +70,497	+36%	+$1.99M	0.01%	653
2022 Q3	$5.52M	Buy	195,221 +29,249	+18%	+$785K	0.01%	712
2022 Q2	$3.68M	Buy	165,972 +41,686	+34%	+$942K	0.01%	826
2022 Q1	$3.62M	Buy	124,286 +14,476	+13%	+$442K	﹤0.01%	872
2021 Q4	$3.61M	Buy	109,810 +4,878	+5%	+$196K	﹤0.01%	900
2021 Q3	$4.84M	Buy	+104,932	New	+$5.07M	0.01%	845

Other funds holding AGIO

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s AGIO Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its Agios Pharmaceuticals (AGIO) stake by 27% in Q2 2023, buying an estimated $4.64M and bringing the position to 882,402 shares worth $25M. The position accounts for 0.03% of the portfolio, ranked #416.

Pictet Asset Management (Switzerland) first reported a position in AGIO in Q3 2021 and has held it in 8 quarters since. 153 funds tracked by Wall St. Rank hold AGIO as of Q2 2023.

Pictet Asset Management (Switzerland) held 882,402 shares of Agios Pharmaceuticals worth $25M as of Q2 2023.
Pictet Asset Management (Switzerland) bought 186,326 Agios Pharmaceuticals shares in Q2 2023, an estimated $4.64M.
Agios Pharmaceuticals made up 0.03% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #416 holding.
Pictet Asset Management (Switzerland) first reported a position in Agios Pharmaceuticals in Q3 2021 and has held it in 8 quarters since.
153 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.